UBS OCONNOR LLC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 109 filers reported holding TREACE MED CONCEPTS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$2,268,082
-21.2%
173,004
+53.8%
0.06%
-37.4%
Q2 2023$2,876,548
-21.5%
112,453
-22.7%
0.09%
-19.5%
Q1 2023$3,666,631
-99.9%
145,559
+9.7%
0.11%
+101.8%
Q3 2022$2,927,000,000
+47.2%
132,637
-4.3%
0.06%
+93.1%
Q2 2022$1,988,000,000138,6370.03%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2022
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,595,387$36,677,9474.40%
EMERALD MUTUAL FUND ADVISERS TRUST 945,973$21,747,9191.35%
EMERALD ADVISERS, LLC 1,188,246$27,317,7761.32%
Perceptive Advisors 1,946,403$44,747,8051.26%
Novo Holdings A/S 637,317$14,651,9180.92%
SECTORAL ASSET MANAGEMENT INC 179,924$4,136,4530.80%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 493,213$11,338,9670.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 139,960$3,2180.50%
TimesSquare Capital Management, LLC 976,000$22,4380.32%
DRIEHAUS CAPITAL MANAGEMENT LLC 770,817$17,721,0830.26%
View complete list of TREACE MED CONCEPTS INC shareholders